Randomized Phase II Trial Comparing Bevacizumab Plus Carboplatin and Paclitaxel With Carboplatin and Paclitaxel Alone in Previously Untreated Locally Advanced or Metastatic Non-Sma... von Johnson, David H, Fehrenbacher, Louis, Novotny, William F, Herbst, Roy S, Nemunaitis, John J, Jablons, David M, Langer, Corey J, DeVore, 3rd, Russell F, Gaudreault, Jacques, Damico, Lisa A, Holmgren, Eric, Kabbinavar, Fairooz

Volltext

Randomized Phase II Trial Comparing Bevacizumab Plus Carboplatin and Paclitaxel With Carboplatin and Paclitaxel Alone in Previously Untreated Locally Advanced or Metastatic Non-Sma... von JOHNSON, David H, FEHRENBACHER, Louis, HOLMGREN, Eric, KABBINAVAR, Fairooz, NOVOTNY, William F, HERBST, Roy S, NEMUNAITIS, John J, JABLON, David M, LANGER, Corey J, DEVORE, Russell F, GAUDREAULT, Jacques, DAMICO, Lisa A

Volltext

Topotecan Versus Observation After Cisplatin Plus Etoposide in Extensive-Stage Small-Cell Lung Cancer: E7593—A Phase III Trial of the Eastern Cooperative Oncology Group von SCHILLER, Joan H, ADAK, Sudeshna, CELLA, David, DEVORE, Russell F, JOHNSON, David H

Volltext

Randomized Phase III Trial of Docetaxel Versus Vinorelbine or Ifosfamide in Patients With Advanced Non–Small-Cell Lung Cancer Previously Treated With Platinum-Containing Chemothera... von FOSSELLA, F. V, DEVORE, R, GANDARA, D, KARP, D, VOKES, E, KRIS, M, KIM, Y, GAMZA, F, HAMMERSHAIMB, L, KERR, R. N, CRAWFORD, J, NATALE, R. R, DUNPHY, F, KALMAN, L, MILLER, V, LEE, J. S, MOORE, M

Volltext

Phase II Trial of Gemcitabine in Refractory or Relapsed Small-Cell Lung Cancer: Eastern Cooperative Oncology Group Trial 1597 von MASTERS, Gregory A, DECLERCK, Lieven, BLANKE, Charles, SANDIER, Alan, DEVORE, Russell, MILLER, Kathy, JOHNSON, David

Volltext

Induction chemotherapy increases perioperative complications in patients undergoing resection for non–small cell lung cancer von Roberts, John R, Eustis, Chad, Devore, Russell, Carbone, David, Choy, Hak, Johnson, David

Volltext

A phase II study of paclitaxel, carboplatin, and hyperfractionated radiation therapy for locally advanced inoperable non–small-cell lung cancer (a Vanderbilt cancer center affiliat... von Choy, Hak, Devore, Russell F, Hande, Kenneth R, Porter, Lester L, Rosenblatt, Paul, Yunus, Furhan, Schlabach, Larry, Smith, Clyde, Shyr, Yu, Johnson, David H

Volltext

Activity of Docetaxel in Platinum-Treated Non–Small-Cell Lung Cancer: Results of a Phase II Multicenter Trial von GANDARA, D. R, VOKES, E, GREEN, M, BONOMI, P, DEVORE, R, COMIS, R, CARBONE, D, KARP, D, BELANI, C

Volltext

A Phase II Study of Carboplatin and Irinotecan in Extensive Stage Small-Cell Lung Cancer von Horn, Leora, Zhao, Zhiguo, Sandler, Alan, Johnson, David, Shyr, Yu, Wolff, Steven, DeVore, Russell F, Laskin, Janessa

Volltext

Weekly Irinotecan and Cisplatin in Advanced Non-Small Cell Lung Cancer: A Multicenter Phase II Study von JAGASIA, Madan H, LANGER, Corey J, JOHNSON, David H, YUNUS, Furhan, RODGERS, John S, SCHLABACH, Larry L, COHEN, Alan G, SHYR, Yu, CARBONE, David P, DEVORE, Russell F

Volltext

Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial von Fehrenbacher, Louis, Dr, Spira, Alexander, MD, Ballinger, Marcus, PhD, Kowanetz, Marcin, PhD, Vansteenkiste, Johan, Prof, Mazieres, Julien, Prof, Park, Keunchil, Prof, Smith, David, MD, Artal-Cortes, Angel, MD, Lewanski, Conrad, MD, Braiteh, Fadi, MD, Waterkamp, Daniel, MD, He, Pei, PhD, Zou, Wei, PhD, Chen, Daniel S, MD, Yi, Jing, PhD, Sandler, Alan, MD, Rittmeyer, Achim, MD

Volltext

Phase II Study of Irinotecan Plus Cisplatin in Patients With Advanced Non–Small-Cell Lung Cancer von DEVORE, R. F, JOHNSON, D. H, MILLER, L. L, CRAWFORD, J, GARST, J, DIMERY, I. W, ECKARDT, J, ECKHARDT, S. G, ELFRING, G. L, SCHAAF, L. J, HANOVER, C. K

Volltext

Multi-Institutional Phase I/II Trial of Paclitaxel, Cisplatin, and Etoposide With Concurrent Radiation for Limited-Stage Small-Cell Lung Carcinoma von LEVITAN, N, DOWLATI, A, SHINA, D, CRAFFEY, M, MACKAY, W, DEVORE, R, JETT, J, REMICK, S. C, CHANG, A, JOHNSON, D

Volltext

A Phase II trial of 6-hydroxymethylacylfulvene (MGI-114, irofulven) in patients with advanced non-small cell cancer previously treated with chemotherapy von DOWELL, Jonathan E, JOHNSON, David H, ROGERS, John S, SHYR, Yu, MCCULLOUGH, Nancy, KROZELY, Peggy, DEVORE, Russell F

Volltext

Phase II trial of sorafenib and erlotinib in advanced pancreatic cancer von Cardin, Dana B., Goff, Laura, Li, Chung‐I, Shyr, Yu, Winkler, Charles, DeVore, Russell, Schlabach, Larry, Holloway, Melanie, McClanahan, Pam, Meyer, Krista, Grigorieva, Julia, Berlin, Jordan, Chan, Emily

Volltext

Epidermal growth factor regulates topoisomerase II activity and drug sensitivity in human KB cells von ALLEN, GREGORY C., LUBAS, SCOTT, WAX, MARK K., DEVORE, RUSSELL F.

Volltext

PHOSPHORYLATION OF TOPOISOMERASE-II BY CASEIN KINASE-II AND PROTEIN-KINASE-C - EFFECTS ON ENZYME-MEDIATED DNA CLEAVAGE RELIGATION AND SENSITIVITY TO THE ANTINEOPLASTIC DRUGS ETOPOS... von DEVORE, RF, CORBETT, AH, OSHEROFF, N

Volltext

Phase I study of the antineovascularization drug CM101 von DEVORE, R. F, HELLERQVIST, C. G, YORK, G. E, ZHANG, M.-H, JOHNSON, D. H, WAKEFIELD, G. B, WAMIL, B. D, THURMAN, G. B, MINTON, P. A, SUNDELL, H. W, YAN, H.-P, CARTER, C. E, WANG, Y.-F

Volltext

Effect of casein kinase II-mediated phosphorylation on the catalytic cycle of topoisomerase II. Regulation of enzyme activity by enhancement of ATP hydrolysis von CORBETT, AH, DEVORE, RF, OSHEROFF, N

Volltext

1747/Does Adjuvant Chemotherapy Impair Quality of Life? A Trial of Adjuvant Navelbine/Cisplatinum for Early Stage Lung Cancer von Bezjak, Andrea, Tim Winton, Keyue Ding, Graham, Barbara, Lesley Seymour, Joseph Ayoub, Livingston, Robert, Eric Vallieres, James Rigas, Todd Demmy, Russell Devore, Kenneth Kessler, Frances Shepherd

Volltext